In correlation with previous observations made in SCCHN preclinical studies [58,59], when CAL27 and FaDu were chronically exposed to cetuximab they displayed increased STAT3 activity relative to their parental lines. Here, STAT3 is linked to head and neck squamous cell carcinoma.